|
1) Buteau J, Spatz ML, Accilli D, et al. Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic β-cell mass. Diabetes. 2006; 55: 1190-6
|
|
|
|
2) Yusta B, Baggio LL, Estall JL, et al. GLP-1 receptor activation improves β cell function and survival following induction of endoplasmic reticulum stress. Cell Metab. 2006; 4: 391-406
|
|
|
|
|
|
3) Zhang J, Tokui Y, Yamagata K, et al. Continuous stimulation of human glucagon-like peptide-1(7-36) amide in a mouse model (NOD) delays onset of autoimmune type1 diabetes. Diabetologia. 2007; 50: 1900-9
|
|
|
|
|
|
4) Kashima Y, Miki T, Shibasaki T, et al. Critical role of cAMP-GEFⅡ-Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem. 2001; 276: 46046-53
|
|
|
|
|
|
5) Ozaki N, Shibasaki T, Kashima Y, et al. cAMP-GEFⅡ is a direct target of cAMP in regulated exocytosis. Nat Cell Biol. 2000; 2: 805-11
|
|
|
|
|
|
6) Thorens B, Deriaz N, Bosco D, et al. Protein kinase A-dependent phosphorylation of GLUT2 in pancreatic β cells. J Biol Chem. 1996; 271: 8075-81
|
|
|
|
|
|
7) Beguin P, Nagashima K, Nishimura M, et al. PKA-mediated phosphorylation of the human KATP channel: separate roles of Kir6. 2 and SUR1 subunit phosphorylation. EMBO J. 1999; 18: 4722-32
|
|
|
|
|
|
8) Safayhi H, Haase H, Kramer U, et al. L-type calcium channels in insulin-secreting cells: biochemical characterization and phosphorylation in RINm5F cells. Mol Endocrinol. 1997; 11: 619-29
|
|
|
|
|
|
9) Sugawara K, Shibasaki T, Mizoguchi A, et al. Rab11 and its effector Rip11 participate in regulation of insulin granule exocytosis. Genes Cells. 2009; 14: 445-56
|
|
|
|
|
|
10) Maximov A, Shin OH, Liu X, et al. Synaptotagmin-12, a synaptic vesicle phosphoprotein that modulates spontaneous neurotransmitter release. J Cell Biol. 2007; 176: 113-24
|
|
|
|
|
|
11) Seino S and Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol Rev. 2005; 85: 1303-42
|
|
|
|
|
|
12) de Rooij J, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature. 1998; 396: 474-7
|
|
|
|
|
|
13) Kawasaki H, Springett GM, Mochizuki N, et al. A family of cAMP-binding proteins that directly activate Rap1. Science. 1998; 282: 2275-9
|
|
|
|
|
|
14) Rehmann H, Das J, Knipscheer P, et al. Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state. Nature. 2006; 439: 625-8
|
|
|
|
|
|
15) Shibasaki T, Takahashi H, Miki T, et al. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci U S A. 2007; 104: 19333-8
|
|
|
|
|
|
16) Zander M, Madsbad S, Madsen JL, et al. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study. Lancet. 2002; 359: 824-30
|
|
|
|
|
|
17) Zhang CL, Katoh M, Shibasaki T, et al. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science. 2009; 325: 607-10
|
|
|
|
|
|
18) Nauck MA, Heimesaat MM, Orskov C, et al. Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest. 1993; 91: 301-7
|
|
|
|
|
|
19) Ma X, Zhang Y, Sewing S, et al. Glucagon stimulates exocytosis in mouse and rat pancreatic α-cells by binding to glucagon receptors. Mol Endocrinol. 2005; 19: 198-212
|
|
|
|
|
|
20) de Heer J, Rasmussen C, Coy DH, et al. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype2) in the perfused rat pancreas. Diabetologia. 2008; 51: 2263-70
|
|
|
|
|
|
21) De Marinis YZ, Salehi A, Ward CE, et al. GLP-1 inhibits and adrenaline stimulates glucagon release by different modulation of N- and L-type Ca2＋ channel-dependent exocytosis. Cell Metab. 2010; 11: 543-53
|
|
|
|
|
|
22) Seino S, Zhang CL, Shibasaki T. Sulfonylurea action Rerevisited. J Diabetes Invest, in press
|
|
|
|
|
|
23) Inagaki N, Gonoi T, Crement JP, et al. Reconstitution of IKATP : an inward rectifier subunit plus the sulfonylurea receptor. Science. 1995; 270: 1166-70
|
|
|
|
|
|
24) Aguilar-Bryan L, Nichols CG, Wechsler SW. Cloning of the βcell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 1995; 268: 423-6
|
|
|
|
|
|
25) Seino S. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol. 1999; 61: 337-62
|
|
|
|
|